Surgery Alone Treatment vs. Surgery with Adjuvant Therapy for Laryngeal Mucoepidermoid Cancer: A Systematic Review. [PDF]
Chiari F +4 more
europepmc +1 more source
Ciclopirox Olamine Inhibits the NLRP3 Inflammasome to Alleviate Inflammatory Diseases
There is no drug targeting the NLRP3 inflammasome that has been approved for use in clinical settings. Ciclopirox olamine (CPX), an antifungal agent approved by the US Food and Drug Administration (FDA), is identified as a specific and potent NLRP3 inflammasome inhibitor. CPX targets the NACHT domain of NLRP3 at Y381 to impair NLRP3 oligomerization and
Xinyu Xia +7 more
wiley +1 more source
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial. [PDF]
Sun Y +64 more
europepmc +1 more source
Comparing the efficacy of immune checkpoint inhibitors with and without microwave ablation in advanced hepatocellular carcinoma in real-world clinical practice: A retrospective cohort study. [PDF]
Wei C +7 more
europepmc +1 more source
Age and Overdose at the Index Attempt Predict Suicide Reattempts After Emergency Admission: A Multicenter Cohort Study. [PDF]
Sasaki T +5 more
europepmc +1 more source
The relationship between histological variants, treatment, and renal outcome of IgA nephropathy: A single-center experience. [PDF]
Tóth B, Dobi D, Kardos M, Pethő Á.
europepmc +1 more source
Postoperative Neutrophil-to-Albumin Ratio as a Prognostic Marker for Patients with Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Observational Cohort Study. [PDF]
Li W, Xiang C, Xie G, Zhang Y.
europepmc +1 more source
Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan. [PDF]
Abe T +16 more
europepmc +1 more source

